The first weekend of April, Yvette Zimmerman, COO and Ellen Dutman, CRA at Pantarhei attended the ENDO congress in Orlando, USA, which is organised by the Endocrine Society. The results from a clinical study with estetrol in healthy men were presented in a poster session.
The CEO of Pantarhei, Herjan Coelingh Bennink, will be presenting at the BioCapital Europe Conference on March 15, 2017 in Amsterdam. An ideal opportunity to meet us and discuss possibilities to collaborate, partner with or invest in Pantarhei’s programmes.
On Friday March 17, 2017 Pantarhei will sponsor a symposium entitled “Estrogens for the treatment of breast cancer”. Lectures will be presented by Herjan Coelingh Bennink (Results of High Dose Estrogen (HDE) treatment of breast cancer), Richard Santen (Effect of estrogens in preclinical breast cancer models) and Andrea Genazzani (Breast cancer: molecular and hormonal basis of metastasis). The session will be chaired by Piero Sismondi.